Effect of Coffeeberry on Mood, Motivation and Cognitive Performance
NCT ID: NCT04974606
Last Updated: 2021-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2016-06-28
2016-12-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Preliminary studies suggest that flavanols and chlorogenic acids can enhance cognitive performance. It is unknown if drinks formulated with flavanols and chlorogenic acids (without high sugar or caffeine) improve cognition or mood to a similar extent as caffeine. Coffeeberry beverage comparisons will be made to a flavored positive control beverage containing caffeine and a flavored placebo beverage.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Coffeeberry on Mood and Cognitive Performance
NCT04975802
Effect of Phytochemicals on Aspects of Cognitive Performance
NCT02167750
Influence of Coffeeberry Ingestion on Soccer Skill Performance
NCT04181619
Dose Effect of a Plant Extract on Fatigue
NCT03870126
Effect of Date Seeds Coffee on Mood and Cognitive Performance
NCT04009564
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Coffeeberry 100 mg beverage
Appearance-matched to the other beverages
Cherry-flavored still beverage
10 oz bottle
Coffeeberry 300 mg beverage
Appearance-matched to the other beverages
Cherry-flavored still beverage
10 oz bottle
Placebo beverage
Appearance-matched to the other beverages
Placebo cherry-flavored still beverage
10 oz bottle
Caffeine 75 mg beverage
Appearance-matched to the other beverages
Cherry-flavored still beverage
10 oz bottle
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cherry-flavored still beverage
10 oz bottle
Placebo cherry-flavored still beverage
10 oz bottle
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-report of good health
Exclusion Criteria
* Report hypersensitivity to caffeine
* Have visual impairment that cannot be corrected with glasses or contact lenses
* Report any food allergies
* Self-reported excessive leisure time physical activity (\> 7 strenuous bouts per week)
* the presence of current gastrointestinal, sleep, or psychiatric disorder,
* Report pregnancy/lactation, illegal drug use, smoker
* failure to demonstrate adequate minimal performance on lab, computer-based cognitive tasks.
* Participation in another clinical trial within past 30 days
17 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
PepsiCo Global R&D
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patrick J O'Connor
Role: PRINCIPAL_INVESTIGATOR
University of Georgia, Athens
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Exercise Psychology Laboratory University of Georgia
Athens, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PEP-1605
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.